In fact, GPx-7 expression was higher in glioblastoma than in low-grade gliomas (oligoastrocytoma, oligodendroglioma, and astrocytoma), while the expression of GPx-7 was higher as the pathological grade increased. This evidence concerns the gene GPX7 and central nervous system cancer.